LawGrids logoLAWGRIDS.ORG

Rule 3, Drugs (Prices Control) Order, 2013: Directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations

Drugs (Prices Control) Order, 2013 - Rule 3

Text of rule 3

Directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations

3. Directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations.– The Government may, - (i) with a view to achieve adequate availability and to regulate the distribution of drugs, in case of emergency or in circumstances of urgency or in case of non-commercial use in public interest, direct any manufacturer of any active pharmaceutical ingredient or bulk drug or formulation to increase the production and to sell such active pharmaceutical ingredient or bulk drug to such other manufacturer(s) of formulations and to direct formulators to sell the formulations to institutions, hospitals or any agency as the case may be; (ii) for the purpose of giving any direction under sub-paragraph (i), call for such information from manufacturers of active pharmaceutical ingredients or bulk drugs or formulations, as it may 2 Substituted vide GSR 686(E), w.e.f. 09-03-2015 the same drug of specified dosages and strengths as listed in the National List of Essential Medicines. [(v) "non-scheduled formulation" means a formulation, which is not included in Schedule - 1.]2 (w) “pharmacoeconomics” means a scientific discipline that compares the therapeutic value of one pharmaceutical drug or drug therapy to another; (x) "price list" means a price list referred to in paragraphs 24 and 25 and includes a supplementary price list; (y) “price to retailer” means the price of a drug at which it is sold to a retailer which includes duties and does not include local taxes; (z) "retail price" means the price fixed by the Government for a new drug under paragraph 5; (za) "retailer" means a dealer carrying on the retail business of sale of drugs to customers; (zb) “scheduled formulation" means any formulation, included in the First Schedule whether referred to by generic versions or brand name; (zc) "schedule" means a Schedule appended to this Order; (zd) "wholesaler" means a dealer or his agent or a stockist engaged in the sale of drugs to a retailer, hospital, dispensary, medical, educational or research institution or any other agency; (ze) “wholesale price index” means annual wholesale price index of all commodities as announced by the Department of Industrial Policy and Promotion, Government of India, from time to time. (2) All other words and expressions used herein and not defined but defined in the Act or the Drugs and Cosmetics Act, 1940 (23 of 1940) shall have the meanings respectively assigned to them in the said Acts. 3. Directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations.— The Government may, - (i) with a view to achieve adequate availability and to regulate the distribution of drugs, in case of emergency or in circumstances of urgency or in case of non-commercial use in public interest, direct any manufacturer of any active pharmaceutical ingredient or bulk drug or formulation to increase the production and to sell such active pharmaceutical ingredient or bulk drug to such other manufacturer(s) of formulations and to direct formulators to sell the formulations to institutions, hospitals or any agency as the case may be; (ii) for the purpose of giving any direction under sub-paragraph (i), call for such information from manufacturers of active pharmaceutical ingredients or bulk drugs or formulations, as it may * Substituted vide GSR 686(E), w.e.f. 09-03-2015 consider necessary and such manufacturer shall furnish the required information within such time the Government may fix.

Previous and next

All provisions of Drugs (Prices Control) Order, 2013

Questions people ask

Is rule 3 of Drugs (Prices Control) Order, 2013 still in force?

No repeal of Drugs (Prices Control) Order, 2013 is recorded.